The Institute for Magnetic Resonance Research was established to benefit Australia through the research, development, application and commercialisation of technologies associated with the use of magnetic resonance for the detection, diagnosis and treatment of human diseases.

The Institute has adopted a multidisciplinary approach to the investigation of medical applications of Magnetic Resonance technology and is currently participating in international trials to determine the clinical benefit of Magnetic Resonance for healthcare outcomes and budgets and to ensure Australia has immediate access to clinical developments in Magnetic Resonance.

The IMRR team is working on the development of suitable devices and protocols for in vivo Magnetic Resonance to allow the simultaneous identification of spatial location and pathological diagnosis of disease states and has a commitment to provide world class training in applications of magnetic resonance technology in the field of medicine.

Currently the IMRR is engaged in the following fields:

• breast cancer
• prostate cancer
• melanoma
• neuro imaging and spectroscopy
• Parkinson's Disease
• pain management
• thyroid cancer
• MR technology development
• monitoring of therapy